Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination

This publication has 46 references indexed in Scilit:

• Non-cholesterol sterols and faecal elimination of cholesterol during statin and fibrate treatment
  Atherosclerosis, 1992
• Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man
  Metabolism, 1992
• Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia
  The American Journal of Medicine, 1991
• Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor
  European Journal of Clinical Pharmacology, 1991
• Influence of Pravastatin, a Specific Inhibitor of HMG-CoA Reductase, on Hepatic Metabolism of Cholesterol
  New England Journal of Medicine, 1990
• Inhibition of Dietary Cholesterol Absorption During Lovastatin (Mevinolin) Treatment
  Clinical Drug Investigation, 1990
• Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter study
  The American Journal of Cardiology, 1988
• Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
  JAMA, 1988
• HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
  New England Journal of Medicine, 1988